Merck Says Januvia Effective In Type 2 Diabetes

by Medindia Content Team on  June 12, 2006 at 5:57 PM Diabetes News   - G J E 4
Merck Says Januvia Effective In Type 2 Diabetes
Merck & Co Inc has said that Januvia, its oral, once-daily medicine for type 2 diabetes has shown promise in combating the disease and had significantly reduced blood sugar levels. This was true when the drug was used alone or in conjunction with two commonly used therapies (metformin or pioglitazone).

Merck presented the results of the Phase III trials at the American Diabetes Association's annual meeting. Treatment with Januvia was also found to improve measures of beta cell function.

Beta cells are found in pancreas and are responsible for producing and releasing insulin. The deficiency of this hormone causes diabetes. Merck said that in the studies, "Januvia had an overall incidence of side effects comparable to placebo and was generally well tolerated."


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Januvia...a good drug for diabetes, but unfortunately very costly..especially for a country like India. I hope some day pharma companies will think beyond business and bring down the cost of such much needed medicines.
drpradeep79 Thursday, July 22, 2010
Is this Januvia available in indian market?
bharath_kumar Saturday, February 27, 2010
Yes, Januvia is available in Indian markets, but you should always consult your doctor before starting any medications
Shwetal Tuesday, June 22, 2010

You May Also Like

View All